AzTrials
AzTrials

MalocclusionPhase 1/2NCT00485602

Orthodontic Treatment With a Part-Time Wearing Esthetic Removable Appliance

A Phase 1/2 study testing orthodontic treatment with "Rafenalign" appliance in people with Malocclusion, run by Hadassah Medical Organization at 1 site in Israel.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The trial is aimed to investigate an orthodontic treatment with a new removable-part-time-wearing appliance, based on "High-Tech" technology. The appliance should be wear only 12-14 hours a day, and is made of a single silicone aligner, made specifically for the patient, using 3-D screening technology of the patient's… Read more about this study

Who is it for?
Ages 8 to 68 yearsHealthy volunteers can take part
Conditions the study is for
Malocclusion
What is being tested?
orthodontic treatment with "Rafenalign" appliance
Type of treatment
Surgery or procedure
How many people
20 participants
Where
1 siteIsrael
Study dates
Dec 2007to not given
Phase
Phase 1/2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 68 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • mild to moderate class I malocclusion
  • good general health
  • good oral hygiene

Who cannot join

  • bad cooperation
  • any mental or health problem
  • severe class I malocclusion, class II or class III malocclusion

Trial locations and contacts

1 site in 1 country.

Meir Redlich, PhD DMD contact

0097226776184

mredlich@zahav.net.il

Israel1 site
  • Hadassah Medical Organization

    Jerusalem, 91120

    Arik Tzukert, DMD, 0097226776095, arik@hadassah.org.il

    Hadas Lemberg, PhD, 0097226777572, lhadas@hadassah.org.il

Other trials in Israel

About this study

The trial is aimed to investigate an orthodontic treatment with a new removable-part-time-wearing appliance, based on "High-Tech" technology.

The appliance should be wear only 12-14 hours a day, and is made of a single silicone aligner, made specifically for the patient, using 3-D screening technology of the patient's malocclusion. The aligner has a designed pathway "built-in" for the tooth to move, from the original position of the malocclusion to the "end point" - the correct position.

Read more

The force system, that is needed in order to generate tooth movement, is produced by tiny air-balloons which are incorporated in the aligner.

The study hypothesis is, that an orthodontic treatment can be done successfully with this part-time wearing appliance.

Read the detailed description

The appliance include:

  • silicone aligner (made specifically for the patient.
  • simple air pump to blow air in the tiny balloons.

The patient is guided to wear the appliance 12-14 hours a day, after filling air in the balloons, under the doctor's instructions.

Clinical examination for follow-up will be done every 4 weeks.

Conditions
Malocclusion
Being tested
orthodontic treatment with "Rafenalign" appliance
Keywords
malocclusion, aligner, crowding, expansion, orthodontic treatment
Medical subject headings
Malocclusion, Crowding

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • orthodontic treatment with "Rafenalign" applianceProcedure or surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. study models

    Measured: every 2 appointments (8 weeks)

Secondary outcomes (1)
  1. occlusal photographs

    Measured: every 3 appointments (12 weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jun 2007 (estimated)
  2. Study startDec 2007

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1/2
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00485602
Sponsor's protocol ID
RAFENALIGN-HMO-CTIL
Status last verified
Jun 2007
First submitted
12 Jun 2007
Last updated
13 Jun 2007
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 1/2 study testing orthodontic treatment with "Rafenalign" appliance in people with Malocclusion, run by Hadassah Medical Organization at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 13 Jun 2007. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Meir Redlich, PhD DMD (0097226776184, mredlich@zahav.net.il), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

study models (time frame: every 2 appointments (8 weeks)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jun 2007; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in